Key result
Digoxin or enalapril significantly improved left ventricular systolic function and decreased mitral regurgitation compared to placebo, with no added benefit from their combination.
Why the study?
Does digoxin, enalapril, or their combination improve echocardiographic parameters of left ventricular systolic function and valvar regurgitation in mildly symptomatic patients with chronic mitral regurgitation?
RCT (n=12)
Double-blind
randomized
Does digoxin, enalapril, or their combination improve echocardiographic parameters of left ventricular systolic function and valvar regurgitation in mildly symptomatic patients with chronic mitral regurgitation?
Isolated administration of digoxin or enalapril improves left ventricular systolic function and reduces mitral regurgitation in mildly symptomatic pediatric patients with chronic mitral regurgitation, with no added benefit from combination therapy.
Supports digoxin or enalapril monotherapy in pediatric chronic MR; extends evidence by showing no added benefit from combination.
OBJECTIVE: To study echocardiographic parameters of left ventricular systolic function and valvar regurgitation under pharmacological influence in mildly symptomatic patients with chronic mitral regurgitation (MR). METHODS: We carried out a double-blind placebo controlled study in 12 patients with MR, mean aged 12.5 years old, who were randomized in 4 phases: A) digoxin; B) enalapril; C) digoxin + enalapril; D) placebo. The medication was administered for 30 days in each phase, and the following variables were analyzed: shortening and ejection fractions, wall stress index of left ventricle, left ventricular meridional end-systolic wall stress, Doppler-derived mean rate of left ventricular pressure rise (mean dP/dt), stroke volume and MR jet area. The clinical variables analysed were heart rate and systemic arterial pressure. RESULTS: No significant variation was observed in the clinical variables analysed. The shortening and ejection fraction, the mean dP/dt and stroke volume significantly increased and the wall stress index of left ventricle, the meridional left ventricular end systolic wall stress and the mitral regurgitation jet area decreased in the phases with medication as compared with that in the placebo phase. CONCLUSION: The parameters of left ventricular systolic function improved significantly and the degree of MR decreased with the isolated administration of digoxin or enalapril in mildly symptomatic patients with chronic MR. The combination of the drugs, however, did not show better results.
No takes yet. Share an insight, caveat, or question.
Rivera et al. (2003) conducted an RCT in chronic mitral regurgitation (n=12). Digoxin, enalapril, or their combination vs. Placebo was evaluated on Echocardiographic parameters of left ventricular systolic function and valvar regurgitation. Digoxin or enalapril significantly improved left ventricular systolic function and decreased mitral regurgitation compared to placebo, with no added benefit from their combination.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: